-+ 0.00%
-+ 0.00%
-+ 0.00%

MacroGenics sells GMP manufacturing operations to Bora Pharmaceuticals for $122.5 million

PUBT·07/07/2026 20:31:09
Listen to the news
MacroGenics sells GMP manufacturing operations to Bora Pharmaceuticals for $122.5 million
  • MacroGenics closed the sale of its GMP drug substance manufacturing operations to Bora Pharmaceuticals for USD 122.5 million, subject to post-closing adjustments.
  • Bora took over manufacturing supporting clinical and commercial production.
  • The Rockville, Maryland manufacturing site and Frederick, Maryland warehouse transferred to Bora.
  • About 140 former MacroGenics employees moved to Bora as part of the transaction.
  • A new supply agreement covers process development and drug substance production for MacroGenics’ pipeline.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MacroGenics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001125345-26-000045), on July 07, 2026, and is solely responsible for the information contained therein.